Cite
HARVARD Citation
Van den Begin, R. et al. (2019). The METABANK score: A clinical tool to predict survival after stereotactic radiotherapy for oligometastatic disease. Radiotherapy and oncology. pp. 113-119. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Van den Begin, R. et al. (2019). The METABANK score: A clinical tool to predict survival after stereotactic radiotherapy for oligometastatic disease. Radiotherapy and oncology. pp. 113-119. [Online].